← FDA ENFORCEMENT
D-0049-2024Class I
KVK-Tech, Inc.
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
KVK-Tech, Inc.
Product type
Drug
Status
Terminated
Report date
2023-10-25
Distribution
Nationwide in the USA and PR
Firm state
PA
Product quantity
1488 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall
Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.
Product description
Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., Newtown, PA 18940, Made in USA, NDC# 10702-013-01.
Code / lot info
Lot # 17853A, Exp. 06/30/2027
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →